We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Renovis (MM) | NASDAQ:RNVS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.10 | 0 | 01:00:00 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Expires: January 31, 2008 Estimated average burden hours per response... 0.5 |
|
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person
*
PENHOET EDWARD |
2. Issuer Name
and
Ticker or Trading Symbol
RENOVIS INC [ RNVS ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
TWO CORPORATE DRIVE |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
SOUTH SAN FRANCISCO, CA 94080 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 5/2/2008 | D | 79028 | D | (1) | 0 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Non-Qualified Stock Option (right to buy) | $3.42 | 5/2/2008 | D | 11111 | 1/26/2007 (2) | 1/25/2017 | Common Stock | 11111 | (3) | 0 | D | ||||
Non-Qualified Stock Option (right to buy) | $4.50 | 5/2/2008 | D | 44444 | 9/24/2003 (4) | 9/23/2013 | Common Stock | 44444 | (5) | 0 | D |
Explanation of Responses: | |
( 1) | Disposed of pursuant to the Merger Agreement ("Merger Agreement") between issurer, Renovis, Inc. ("RNVS") and Evotec AG in exchange for 41,655 American Depositary Shares ("ADSs") of Evotec AG on the effective date of the merger. |
( 2) | Date shown is the date of the option grant. The option vests in substantially equal quarterly installments over the 12 month period following the date of the grant. |
( 3) | This option converted into an option to acquire 5,856 American Depositary Shares ("ADSs") of Evotec AG at an exercise price of $6.49 per share pursuant to the terms of the Merger Agreement among Renovis, Inc. and Evotec AG. |
( 4) | Date shown is the date of the option grant. The option vests in substantially equal monthly installments over the 24 month period following the date of the grant. |
( 5) | This option converted into an option to acquire 23,426 American Depositary Shares ("ADSs") of Evotec AG at an exercise price of $8.54 per share pursuant to the terms of the Merger Agreement among Renovis, Inc. and Evotec AG. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
PENHOET EDWARD
TWO CORPORATE DRIVE SOUTH SAN FRANCISCO, CA 94080 |
X |
|
|
|
Signatures
|
||
/s/ George Fraley, by power of attorney | 5/8/2008 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Renovis (MM) Chart |
1 Month Renovis (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions